Skip to main content

Uddin Laboratory for Ocular Imaging

Research

Research Program:

  1. American Diabetic Association

Title: Gene therapy in Diabetic Retinopathy

Role: PI

Dollar amount: $ 345,000

Start date 12/2022, End date: 11/2025

  1. International Retinal Research Foundation (IRRF) Pilot Grant

Title: Gene silencing in age-related macular degeneration (AMD)

Role: PI

Dollar amount: $ 350,000

Start date 07/2023, End date: 06/2026

Completed

  1. National Institute of Health R01EY029693

Title: In vivo molecular imaging of vascular disease the retina

Role: PI

Dollar amount: $ 2,700,000

Start date 3/2013, End date: 5/2024.

  1. National Institute of Health R01EY023397

Title: In vivo molecular imaging of the retina

Role: PI

Dollar amount: $ 2,098,330

Start date 3/2019, End date: 2/2025.

  1. BrightFocus  Foundation  Macular  Degeneration  Research  Grant

Title: Hairpin-DNA functionalized nanoformulation for AMD

Role: PI

Dollar amount: $ 200,000

Start date 7/2019, End date: 6/2022.

  1. National  Institute  of  Health  sponsored  MICROMouse  Program  (MMPC)

Title: Hairpin-DNA functionalized nanoformulation for AMD

Role: PI

Dollar amount: $ 75,000

Start date 01/2018, End date: 12/2018.

  1. Knights  Templar  Eye  Foundation  Pediatric  Ophthalmology  Career  Starter  Grant

Title: In vivo Imaging of Retinal Hypoxia in a Preclinical Model  of  Retinopathy  of  Prematurity

Role: PI

Dollar amount: $ 130,000

Start date 07/2016, End date: 03/2019.

  1. Carl  Marshall  Reeves  &  Mildred  Almen  Reeves  Foundation

Title: Equipemtn Grant age-related macular degeneration (AMD)

Role: PI

Dollar amount: $ 227,100

Start date 10/2019, End date: 09/2024.

 

 

 

Research Interests:

Uddin Lab is focused on the development of molecular imaging technologies including optical imaging, optical coherence tomography (OCT) and nano-scale engineering to identify molecular targets for early disease-detection and treatments in ophthalmology, vascular medicine and oncology.

Dr. Uddin is currently using optical imaging techniques and nanotechnology-based approaches for diagnosis and drug delivery in preclinical models of diabetic retinopathy (DR), retinopathy of prematurity (ROP), retinal vein occlusion (RVO) and age-related macular degeneration (AMD).

Dr. Uddin is highly collaborative and his long-term collaborators are Dr. John S. Penn and Dr. Craig Duvall.